Skip to content

#DEA

10 NovTue
  1. Federal Register: DEA and FDA documents (US)40

    DEA proposes 2027 production quotas for Schedule I and II controlled substances and list I chemicals

    The US Drug Enforcement Administration has proposed 2027 aggregate production quotas for Schedule I and II controlled substances and an assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine and phenylpropanolamine. Written comments are due by December 10, 2026, under Docket No. DEA-1730P, after which the Administrator will publish a final order.

30 SepWed
  1. MAPS62

    MAPS opposes DEA proposal to place five tryptamines in Schedule I

    MAPS has stated its opposition to a DEA proposal to place five little-known psychedelic compounds, 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT, in Schedule I of the Controlled Substances Act. The organisation says this is the agency's second attempt at the same scheduling action, after an earlier version was withdrawn in 2022 following pushback from researchers and legal advocates.